Cough, Cold and Allergy (Hay Fever) Remedies in New Zealand

Cough, cold and allergy remedies in New Zealand is set to see slow retail current value growth in 2024. During the period 2020-2021, there were movement restrictions and reduced levels of social interaction due to the government response to the COVID-19 pandemic. This meant that levels of seasonal cold and flu reduced, although demand for cough, cold and allergy remedies was instead driven by COVID-19 symptoms.

The Cough, Cold and Allergy (Hay Fever) Remedies in New Zealand report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.